DOSE OF REALITY: NEW ANALYSES UNDERSCORE HOW BIG PHARMA’S EGREGIOUS PRICING OF WEIGHT LOSS DRUGS IS UNSUSTAINABLE
Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of Big Pharma’s Out-of-Control Prices on GLP-1s Two new analyses released Wednesday highlight how the egregious prices set by Big Pharma on GLP-1 weight loss drugs are unsustainable for U.S. patients and the U.S. health care system. The first analysis in the
0 CommentsComment on Facebook